Patent: 10,286,004
✉ Email this page to a colleague
Summary for Patent: 10,286,004
Title: | Targeting-enhanced anticancer nanoparticles and preparation methods of same |
Abstract: | Targeting-enhanced anticancer nanoparticles and preparation methods for the nanoparticles are provided. In particular, this invention provides targeting-enhanced anticancer nanoparticles comprising non-covalently bound anticancer drugs, serum albumins as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties. The targeting-enhanced anticancer nanoparticles described in the present invention are characterized by non-covalently bound constituents: anticancer drugs, serum albumin as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties, thus preventing common toxic side effects, enhancing the structural stability of nanoparticles, and enhancing tumor targeting by treatment with electromagnetic waves due to the activity of porphyrin, without structural and functional changes. Taken together, the present invention provides a chemotherapeutic method that maximizes drug delivery/tumor targeting and is expected to be a successful therapy for both early-stage and late-stage cancer. |
Inventor(s): | Kim; Hyeon Jin (Wanju-gun, KR), Hong; Seong Tshool (Jeonju-si, KR), Chung; Hea Jong (Jeonju-si, KR), Joo; Min Kyu (Jeonju-si, KR), Cho; Hea Guk (Gwangju, KR), Hong; Jinny (Jeonju-si, KR) |
Assignee: | JINIS CO., LTD. (Wanju-gun, KR) |
Application Number: | 15/481,950 |
Patent Claims: | see list of patent claims |
Details for Patent 10,286,004
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | PANHEMATIN | hemin for injection | For Injection | 101246 | 07/20/1983 | ⤷ Try a Trial | 2033-05-02 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |